SHS appoints Sascha Alilovic as managing partner

Alilovic joined SHS as a partner in 2018, but has been assisting the GP with exit transactions and fundraising since 2017, the firm said in a statement. He has experience in healthcare transactions, and was head of corporate finance and corporate development at Germany-based biopharmaceutical company MorphoSys prior to joining SHS.

SHS focuses on growth investments in the healthcare sector, particularly in medical technology and life sciences. It is currently investing from its fifth fund, which held a final close in July 2019 on €130m.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• GPs
• DACH
• people moves
• Germany